Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More
Xconomy
JULY 1, 2016
To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. PureTech also bucked the Brexit fallout this week.
59 
Let's personalize your content